CYCC Bio Green Med Solution Inc.


$ 1.76 $ -0.04 (-2.2 %)    

Friday, 31-Oct-2025 15:40:25 EDT
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 1.78
$ 1.79
$ 1.60 x 100
$ 2.05 x 100
$ 1.61 - $ 1.85
$ 1.61 - $ 101.30
736,163
na
na
$ 1.24
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cyclacel-pharmaceuticals-exchanges-series-c-warrants-for-559395-common-shares-in-agreement-with-accredited-investors

On September 4, 2025, Cyclacel Pharmaceuticals, Inc. (the "Company") entered into a Warrant Exchange Agreement (the ...

 cyclacel-pharmaceuticals-stock-up-346-in-massive-after-hours-rally

After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 3...

 reported-earlier-cyclacel-announces-new-findings-supporting-use-of-plogosertib-in-biliary-tract-cancer-patients-with-high-bubr1-expression

  Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION